Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP

Abstract Standard therapy for gastric diffuse large B‐cell lymphoma (DLBCL) is considered to be chemotherapy with or without involved‐field radiation therapy. Although R‐CHOP therapy alone is widely used for DLBCL with gastric lesions (DLBCL‐GL), the outcome and incidence of treatment‐related gastri...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomohiro Kadota, Sachiko Seo, Hiroe Fuse, Genichiro Ishii, Kuniaki Itoh, Tomonori Yano, Kazuhiro Kaneko, Kunihiro Tsukasaki
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1982
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576175532146688
author Tomohiro Kadota
Sachiko Seo
Hiroe Fuse
Genichiro Ishii
Kuniaki Itoh
Tomonori Yano
Kazuhiro Kaneko
Kunihiro Tsukasaki
author_facet Tomohiro Kadota
Sachiko Seo
Hiroe Fuse
Genichiro Ishii
Kuniaki Itoh
Tomonori Yano
Kazuhiro Kaneko
Kunihiro Tsukasaki
author_sort Tomohiro Kadota
collection DOAJ
description Abstract Standard therapy for gastric diffuse large B‐cell lymphoma (DLBCL) is considered to be chemotherapy with or without involved‐field radiation therapy. Although R‐CHOP therapy alone is widely used for DLBCL with gastric lesions (DLBCL‐GL), the outcome and incidence of treatment‐related gastric complications following R‐CHOP are not well known. This study aimed to evaluate the outcome after R‐CHOP therapy in patients with gastric DLBCL including gastric complications and to identify risk factors for the complications. Consecutive patients with newly diagnosed DLBCL‐GL treated with R‐CHOP between 2003 and 2014 were retrospectively evaluated. DLBCL‐GL was defined only when pathologically confirmed in the stomach. Of the 96 patients with DLBCL‐GL, 63 patients were diagnosed with gastric symptoms. Eighty‐eight patients (92%) completed six to eight cycles of R‐CHOP. The complete remission (CR) rate was 86%, and 3‐year and 5‐year overall survival rates were 80% and 73%, respectively. Patients were well stratified according to the Revised International Prognostic Index (R‐IPI). Complication rate was 8% (8/96); seven patients had bleeding and three had stenosis. No patients had gastric perforation. Bleeding occurred during the first cycle of R‐CHOP in five patients (5/7, 71%). Patients with gastric complications had a lower R‐CHOP completion rate (50%, P = 0.001) and a lower CR rate (25%, P < 0.001) than those without complications. A low serum albumin level at diagnosis was the only risk factor identified for gastric complications (P = 0.001) and six of the eight patients with complications were shown to be at stage IV. Further studies of DLBCL‐GL are warranted to identify patients at high risk for gastric complications and to provide better treatment strategies.
format Article
id doaj-art-082cb337a06645a69398e0a00c19e34d
institution Kabale University
issn 2045-7634
language English
publishDate 2019-03-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-082cb337a06645a69398e0a00c19e34d2025-01-31T08:47:42ZengWileyCancer Medicine2045-76342019-03-018398298910.1002/cam4.1982Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOPTomohiro Kadota0Sachiko Seo1Hiroe Fuse2Genichiro Ishii3Kuniaki Itoh4Tomonori Yano5Kazuhiro Kaneko6Kunihiro Tsukasaki7Department of Gastroenterology, Endoscopy Division National Cancer Center Hospital East Kashiwa JapanDepartment of Hematology National Cancer Center Hospital East Kashiwa JapanDepartment of Hematology Matsudo City General Hospital Matsudo Chiba JapanDivision of Pathology, Exploratory Oncology Research & Clinical Trial Center (EPOC) National Cancer Center Kashiwa Chiba JapanDepartment of Hematology National Cancer Center Hospital East Kashiwa JapanDepartment of Gastroenterology, Endoscopy Division National Cancer Center Hospital East Kashiwa JapanDepartment of Gastroenterology, Endoscopy Division National Cancer Center Hospital East Kashiwa JapanDepartment of Hematology National Cancer Center Hospital East Kashiwa JapanAbstract Standard therapy for gastric diffuse large B‐cell lymphoma (DLBCL) is considered to be chemotherapy with or without involved‐field radiation therapy. Although R‐CHOP therapy alone is widely used for DLBCL with gastric lesions (DLBCL‐GL), the outcome and incidence of treatment‐related gastric complications following R‐CHOP are not well known. This study aimed to evaluate the outcome after R‐CHOP therapy in patients with gastric DLBCL including gastric complications and to identify risk factors for the complications. Consecutive patients with newly diagnosed DLBCL‐GL treated with R‐CHOP between 2003 and 2014 were retrospectively evaluated. DLBCL‐GL was defined only when pathologically confirmed in the stomach. Of the 96 patients with DLBCL‐GL, 63 patients were diagnosed with gastric symptoms. Eighty‐eight patients (92%) completed six to eight cycles of R‐CHOP. The complete remission (CR) rate was 86%, and 3‐year and 5‐year overall survival rates were 80% and 73%, respectively. Patients were well stratified according to the Revised International Prognostic Index (R‐IPI). Complication rate was 8% (8/96); seven patients had bleeding and three had stenosis. No patients had gastric perforation. Bleeding occurred during the first cycle of R‐CHOP in five patients (5/7, 71%). Patients with gastric complications had a lower R‐CHOP completion rate (50%, P = 0.001) and a lower CR rate (25%, P < 0.001) than those without complications. A low serum albumin level at diagnosis was the only risk factor identified for gastric complications (P = 0.001) and six of the eight patients with complications were shown to be at stage IV. Further studies of DLBCL‐GL are warranted to identify patients at high risk for gastric complications and to provide better treatment strategies.https://doi.org/10.1002/cam4.1982bleedingdiffuse large B‐cell lymphoma with gastric lesionsgastric complicationsmortalityR‐CHOP
spellingShingle Tomohiro Kadota
Sachiko Seo
Hiroe Fuse
Genichiro Ishii
Kuniaki Itoh
Tomonori Yano
Kazuhiro Kaneko
Kunihiro Tsukasaki
Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
Cancer Medicine
bleeding
diffuse large B‐cell lymphoma with gastric lesions
gastric complications
mortality
R‐CHOP
title Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
title_full Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
title_fullStr Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
title_full_unstemmed Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
title_short Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
title_sort complications and outcomes in diffuse large b cell lymphoma with gastric lesions treated with r chop
topic bleeding
diffuse large B‐cell lymphoma with gastric lesions
gastric complications
mortality
R‐CHOP
url https://doi.org/10.1002/cam4.1982
work_keys_str_mv AT tomohirokadota complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT sachikoseo complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT hiroefuse complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT genichiroishii complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT kuniakiitoh complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT tomonoriyano complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT kazuhirokaneko complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop
AT kunihirotsukasaki complicationsandoutcomesindiffuselargebcelllymphomawithgastriclesionstreatedwithrchop